Deoxycholic Acid, a Metabolite of Circulating Bile Acids, and Coronary Artery Vascular Calcification in CKDAnna Jovanovich, Makoto Miyazaki, Tamara Isakova et al.|American Journal of Kidney Diseases|2017Cited by 84
Deoxycholic Acid and Risks of Cardiovascular Events, ESKD, and Mortality in CKD: The CRIC StudyRebecca Frazier, Tamara Isakova, Joshua D. Bundy et al.|Kidney Medicine|2021Cited by 26
Randomized, Placebo-Controlled Trial of Rifaximin Therapy for Lowering Gut-Derived Cardiovascular Toxins and Inflammation in CKDCassandra Kimber, Jason R. Stubbs, Shiqin Zhang et al.|Kidney360|2020Cited by 22
Deoxycholic Acid (DCA) and Cognitive Impairment and Decline in the Chronic Renal Insufficiency Cohort (CRIC) StudyKristen L. Nowak, Anna Jovanovich, Makoto Miyazaki et al.|Journal of the American Society of Nephrology|2021Cited by 1
Arterial Stiffness and AKI in the Atherosclerosis Risk in Communities (ARIC) StudyEster Oh, Anna Jovanovich, Aditya Surapaneni et al.|Journal of the American Society of Nephrology|2023Cited by 0